Real-time enrollment status for this metastatic castration-resistant prostate carcinoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:46 AM UTC
| NCT Number | NCT06236139 |
| Recruiting Status | Recruiting |
| Condition | Metastatic Castration-Resistant Prostate Carcinoma |
| Phase | Clinical Trial |
| Target Enrollment | 48 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Fred Hutchinson Cancer Center |
| Last Updated on CT.gov | June 26, 2026 (2 weeks ago) |
As of July 13, 2026: Clinical trial NCT06236139 is currently recruiting participants. This clinical trial study for metastatic castration-resistant prostate carcinoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Fred Hutchinson Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06236139 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06236139 was last updated 2 weeks ago (June 26, 2026). HelloStudys verifies this status automatically.